Stay updated on Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.

Latest updates to the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision history updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedSite revision updated to v3.5.0, replacing the previous v3.4.3 version.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed. This indicates a minor platform update with no changes to study page content or visible functionality.SummaryDifference0.0%

- Check71 days agoChange DetectedA minor site update adds Revision: v3.4.2 and removes the previous maintenance notice (Revision: v3.4.1) related to government funding.SummaryDifference0.3%

- Check78 days agoChange DetectedA government funding notice and site status message are now displayed, and the revision label updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check85 days agoChange DetectedAdded a 'Show glossary' option and updated wording for No FEAR Act data, capitalization of QC criteria labels, and revision notes (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.